The Role of Transforming Growth Factor-p and Enhanced Interstitial Fibrosis in Ketamine-Induced Ulcerative Cystitis in a Rat Model

探討轉化生長激素β對增加K他命潰瘍性膀胱炎大白鼠間質纖維化的角色

李懿倫(Yi-Lun Lee)；張美玉(Mei-Yu Jang)；莊淑棉(Shu-Mien Chuang)；吳文正(Wen-Jeng Wu)；沈榮宗(Jung-Tsung Shen)；龍震宇(Cheng-Yu Long)；阮雍順(Yung-Shun Juan)

轉化生長激素β ； 間質纖維化 ； K他命 ； 膀胱炎 ； Transforming growth factor-β (TGF-β) ； Interstitial fibrosis ； Ketamine ； Cystitis

醫學與健康期刊

4卷2期（2015 / 09 / 01）

27 - 39

英文

目的：探討轉化生長激素β（TGF-β）的表現是否會正向調節制也命注射後膀胱間質纖維化的反應，並且以大白鼠K他命藥物成癮模式評估則也命注射後需多少時間引發明顯變化。方法：將30隻Sprague-Dawley大白鼠分成三組，每組之大白鼠會接受14到28天的生理食鹽水或K他命（25毫克／公斤／天）腹膜內注射。每組每周檢測膀胱壓力及代謝籠之解尿型態。以西方墨點法分析膀胱組織發炎蛋白TGF-β，纖維化蛋白如纖連蛋白（fibronectin）和第一型膠原蛋白（type I collagen）及細胞外訊號調節激活脢1/2（ERK1/2）的表現。結果：K他命明顯造成頻尿及不自主膀胱收縮之膀胱過動症狀。Masson's trichrome染色顯示K他命會減少尿路上皮厚度但會增加膠原蛋白比平滑肌纖維的比率，並且惡化間質纖維化的現象。K他命注射後會有發炎及纖維化標記如TGF-β，fibronectin和type I collagen表現增加的變化。ERK1/2的密度也會隨著K他命注射而增加。結論：K他命注射28天後會造成膀胱的頻繁收縮並減少膀胱適應性。K他命會誘導ERK1/2的活化及TGF-β的過度表現，可能藉此調節K他命所引發膀胱纖維化的病理生理作用。

Objectives. To investigate whether the expression of transforming growth factor-β (TGF-β) is up-regulated in interstitial fibrosis and further evaluate the progression of this disease in rats addicted to ketamine and how long it would take for ketamine affect this change. Methods. Thirty Sprague-Dawley (SD) rats were classified into three groups, each receiving either saline or ketamine (25mg/kg/day) by intraperitoneal injection over a period of 14 or 28 days. In each group, cystometry and metabolic cage micturition pattern study were performed weekly. The expressions of transforming growth factor-β (TGF-β), fibrosis proteins (fibronectin and type I collagen) and extracellular signal-regulated kinase 1/2 (ERK1/2) in bladder tissues were examined by Western blot analysis. Results. Ketamine treatment resulted in bladder hyperactivity with a significant increase in micturition frequency and non voiding contraction. Masson's trichrome stain showed ketamine treatment decreased urothelium thickness while increasing collagen to smooth muscle ratio and exacerbated interstitial fibrosis. These alterations were accompanied by increases in the expressions of inflammatory and fibrosis markers, TGF-β, fibronectin and type I collagen after ketamine treatment. The density of the phosphorylated ERK1/2 was also increased. Conclusion. Ketamine administration resulted in frequent bladder contractions and decreased bladder compliance after 28 days ketamine treatment. Ketamine induced the activation of phosphorylated ERK1/2 and overexpression of TGF-β, possibly regulating the pathophysiology of fibrosis in ketamine-induced cystitis.

1. Cannon, TW,Damaser, MS(2001).Effects of anesthesia on cystometry and leak point pressure of the female rat.Life Sci,69,1193-202.
2. Chen, WC,Hayakawa, S,Shimizu, K,Chien, CT,Lai, MK(2004).Catechins prevents substance P-induced hyperactive bladder in rats via the downregulation of ICAM and ROS.Neurosci Lett,367,213-7.
3. Chu, PS,Ma, WK,Wong, SC(2008).The destruction of the lower urinary tract by ketamine abuse: a new syndrome?.BJU Int,102,1616-22.
4. Chuang, SM,Liu, KM,Li, YL(2013).Dual involvements of cyclooxygenase and nitric oxide synthase expressions in ketamine-induced ulcerative cystitis in rat bladder.Neurourol Urodyn,32,1137-43.
5. Chung, CW,Zhang, QL,Qiao, LY(2010).Endogenous nerve growth factor regulates collagen expression and bladder hypertrophy through Akt and MAPK pathways during cystitis.J Biol Chem,285,4206-12.
6. Colebunders, B,Van Erps, P(2008).Cystitis due to the use of ketamine as a recreational drug: a case report.J Med Case Rep,2,219.
7. Cottrell, A,Warren, K,Ayres, R,Weinstock, P,Kumar, V,Gillatt, D(2008).The destruction of the lower urinary tract by ketamine abuse: a new syndrome?.BJU Int,102,1178-9.
8. Derynck, R,Zhang, YE(2003).Smad-dependent and Smad-independent pathways in TGF-beta family signalling.Nature,425,577-84.
9. Ghosh, AK(2002).Factors involved in the regulation of type I collagen gene expression: implication in fibrosis.Exp Biol Med,227,301-14.
10. Guo, X,Wang, XF(2009).Signaling cross-talk between TGF-β/BMP and other pathways.Cell Res,19,71-88.
11. Irwin, P,Galloway, NT(1993).Impaired bladder perfusion in interstitial cystitis: a study of blood supply using laser Doppler flowmetry.J Urol,149,890-2.
12. Jang, MY,Long, CY,Chuang, SM(2012).Sexual dysfunction in women with ketamine cystitis: a case-control study.BJU Int,110,427-31.
13. Juan, YS,Chuang, SM,Lee, YL(2012).Green tea catechins decrease oxidative stress in surgical menopause-induced overactive bladder in a rat model.BJU Int,110,236-44.
14. Juan, YS,Chuang, SM,Long, CY(2012).Neuroprotection of green tea catechins on surgical menopause-induced overactive bladder in a rat model.Menopause,19,346-54.
15. Juan, YS,Levin, RM,Chuang, SM(2008).The beneficial effect of coenzyme Q10 and lipoic acid on obstructive bladder dysfunction in the rabbit.J Urol,180,234-40.
16. Kang, NS,Yim, HE,Bae, IS(2003).ACE inhibition modulates transforming growth factor-beta receptors in the young rat.Pediatr Nephrol,18,865-71.
17. Karimi-Googheri, M,Daneshvar, H,Nosratabadi, R(2014).Important roles played by TGF-β in hepatitis B infection.J Med Virol,86,102-8.
18. Kohan, M,Muro, AF,White, ES,Berkman, N(2010).EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signaling.FASEB J,24,4503-12.
19. Leask, A,Abraham, DJ(2004).TGF-beta signaling and the fibrotic response.FASEB J,18,816-27.
20. Ozcan, A,Korkmaz, A,Oter, S,Coskun, O(2005).Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.Arch Toxicol,79,461-5.
21. Pannu, J,Nakerakanti, S,Smith, E,Dijke, PJ,Trojanowska, M(2007).Transforming growth factorbeta receptor typeI-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.J Biol Chem,282,10405-13.
22. Papakrivopoulou, J,Lindahl, GE,Bishop, JE,Laurent, GJ(2004).Differential roles of extracellular signal-regulated kinase 1/2 and p38MAPK in mechanical load-induced procollagen alpha1(I) gene expression in cardiac fibroblasts.Cardiovasc Res,61,736-44.
23. Park, SH,Cho, HJ,Jeong, YJ(2014).Melittin inhibits TGF-β-induced pro-fibrotic gene expression through the suppression of the TGFβRII-Smad,ERK1/2 and JNK-mediated signaling pathway.Am J Chin Med.,42,1139-52.
24. Pons, AR,Sauleda, J,Noguera, A(2005).Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease.Eur Respir J,26,60-6.
25. Rodriguez, LV,Wang, B,Shortliffe, LM(2004).Structural changes in the bladder walls of pregnant and hormone-treated rats: correlation with bladder dynamics.BJU Int,94,1366-72.
26. Sakai, K,Jawaid, S,Sasaki, T,Bou-Gharios, G,Sakai, T(2014).Transforming growth factor-β-independent role of connective tissue growth factor in the development of liver fibrosis.Am J Pathol,184,2611-7.
27. Shapiro, E,Becich, MJ,Perlman, E,Lepor, H(1991).Bladder wall abnormalities in myelodysplastic bladders: a computer assisted morphometric analysis.J Urol,145,1024-9.
28. Varga, J,Rosenbloom, J,Jimenez, SA(1987).Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts.The Biochem J,247,597-604.
29. Wang, H,Xi, S,Xu, Y(2013).Sodium arsenite induces cyclooxygenase-2 expression in human uroepithelial cells through MAPK pathway activation and reactive oxygen species induction.Toxico In Vitro,27,1043-8.
30. Xiao, HB,Liu, RH,Ling, GH(2012).HSP47 regulates ECM accumulation in renal proximal tubular cells induced by TGF-beta1 through ERK1/2 and JNK MAPK pathway.Am J Physiol Renal Physiol,303,757-65.
31. Xiao, HB,Liu, RH,Ling, GH(2012).HSP47 regulates ECM accumulation in renal proximal tubular cells induced by TGF-beta1 through ERK1/2 and JNK MAPK pathway.Am J Physiol Renal Physiol,303,F757-65.
32. Yeung, LY,Rudd, JA,Lam, WP,Mak, YT,Yew, DT(2009).Mice are prone to kidney pathology after prolonged ketamine addiction.Toxicol Lett,191,275-8.